Thus, the release of VEGF-B would allow tissues with a high metabolic turnover, including tumors, to meet their demand for fuel. In the context of pancreatic b-cell biology
As a result, in arrangement with the decreased tumor measurement on transgenic expression of VEGF-B in tumorous pancreatic b-cells, Vegfb-deficient RIP1-Tag2 mice current with greater tumors that harbor morphological modifications…